Tibialis Posterior Tenosynovitis as a First Presenting Feature of Pre-clinical Rheumatoid Arthritis: A Case Report and Literature Review

Authors

  • Sabin Pokharel National Trauma Center, Mahaboudha, Kathmandu, Nepal
  • Arun Khatri Hospital and Rehabilitation Center for Disabled Children (HRDC), Banepa, Nepal
  • Rajendra Yonjan Hospital and Rehabilitation Center for Disabled Children (HRDC), Banepa, Nepal
  • Yam Prakash Gurung Hospital and Rehabilitation Center for Disabled Children (HRDC), Banepa, Nepal

Keywords:

Methotrexate, Rheumatoid Arthritis, Tenosynovitis, Tibialis Posterior Dysfunction

Abstract

Tenosynovitis in Preclinical Rheumatoid Arthritis (RA) has been reported. The Tibialis posterior (TP) tendon is the second most commonly affected tendon in the foot and ankle in established RA, but in preclinical RA has not been reported.

In this case report, we present a 27 years old lady from Dhading, Nepal, with Preclinical RA with first presentation with Tibialis posterior Tenosynovitis. She was anti-cyclic citrullinated Peptide (CCP) positive but had no arthralgia or morning stiffness. Initial treatment with Non-Steroidal anti-inflammatory drugs failed to alleviate her symptoms. Methotrexate helped improve her symptoms.

Downloads

Download data is not yet available.
Abstract
12
PDF
8

Downloads

Published

2023-12-31

How to Cite

Pokharel, S., Khatri, A., Yonjan, R., & Gurung, Y. P. (2023). Tibialis Posterior Tenosynovitis as a First Presenting Feature of Pre-clinical Rheumatoid Arthritis: A Case Report and Literature Review. Nepal Orthopaedic Association Journal, 9(2), 33–35. Retrieved from https://www.nepjol.info/index.php/NOAJ/article/view/61609

Issue

Vol. 9 No. 2 (2023)

Section

Case Report & Review of Literature

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

CC BY-NC-ND This license allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.